229 related articles for article (PubMed ID: 25104453)
1. ACE2/Ang-(1-7) signaling and vascular remodeling.
Zhang Z; Chen L; Zhong J; Gao P; Oudit GY
Sci China Life Sci; 2014 Aug; 57(8):802-8. PubMed ID: 25104453
[TBL] [Abstract][Full Text] [Related]
2. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
3. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
5. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
6. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.
Rodrigues Prestes TR; Rocha NP; Miranda AS; Teixeira AL; Simoes-E-Silva AC
Curr Drug Targets; 2017; 18(11):1301-1313. PubMed ID: 27469342
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis.
Cao X; Yang F; Shi T; Yuan M; Xin Z; Xie R; Li S; Li H; Yang JK
Sci Rep; 2016 Feb; 6():21592. PubMed ID: 26883384
[TBL] [Abstract][Full Text] [Related]
8. [The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases].
Kanda T; Itoh H
Nihon Rinsho; 2012 Sep; 70(9):1487-91. PubMed ID: 23012792
[TBL] [Abstract][Full Text] [Related]
9. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
[TBL] [Abstract][Full Text] [Related]
10. ACE2: a new target for cardiovascular disease therapeutics.
Raizada MK; Ferreira AJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
[TBL] [Abstract][Full Text] [Related]
11. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
13. ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury.
Yang G; Chu PL; Rump LC; Le TH; Stegbauer J
Antioxid Redox Signal; 2017 Apr; 26(12):645-659. PubMed ID: 27889958
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
Santos RA; Ferreira AJ; Verano-Braga T; Bader M
J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
[TBL] [Abstract][Full Text] [Related]
15. [Effects of ACE2-Ang 1-7-Mas axis on blood vessel].
Liu CQ; Huang Y; Lu LM
Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):43-8. PubMed ID: 17438952
[TBL] [Abstract][Full Text] [Related]
16. ACE and ACE2 in inflammation: a tale of two enzymes.
Gaddam RR; Chambers S; Bhatia M
Inflamm Allergy Drug Targets; 2014; 13(4):224-34. PubMed ID: 25019157
[TBL] [Abstract][Full Text] [Related]
17. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.
Iwata M; Cowling RT; Yeo SJ; Greenberg B
J Mol Cell Cardiol; 2011 Oct; 51(4):542-7. PubMed ID: 21147120
[TBL] [Abstract][Full Text] [Related]
18. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis provides a new target for the treatment of cardiac remodeling and heart failure].
Yang L; Huang Y; He Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Nov; 31(11):1425-1428. PubMed ID: 31898578
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.
Zhang Y; Liu J; Luo JY; Tian XY; Cheang WS; Xu J; Lau CW; Wang L; Wong WT; Wong CM; Lan HY; Yao X; Raizada MK; Huang Y
Antioxid Redox Signal; 2015 Oct; 23(11):880-92. PubMed ID: 25867182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]